Pharma Mar S.A. is a leading biopharmaceutical company based in Spain, focused on the discovery and development of innovative marine-based drugs for oncology purposes. Harnessing compounds derived fro... Pharma Mar S.A. is a leading biopharmaceutical company based in Spain, focused on the discovery and development of innovative marine-based drugs for oncology purposes. Harnessing compounds derived from the sea, Pharma Mar aims to treat various forms of cancer with novel therapies. The company’s commitment to leveraging unique marine ecosystems has led to the development of several proprietary anticancer products that contribute to breakthroughs in medical treatments. Pharma Mar operates across the globe, distributing its products through its extensive network in key international markets. The company not only plays a pivotal role in the oncology sector but also invests in continuous research and development to uphold its competitive edge in marine biotechnology. Through strategic partnerships and collaborations with leading research institutions and universities, Pharma Mar strives to expand its pipeline and explore further therapeutic applications of marine-derived compounds. In the financial markets, Pharma Mar is recognized for its innovation-driven approach and the specialized niche it occupies, making it a vital entity in advancing cancer treatment solutions.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

Climate Targets data not yet covered for Pharma Mar

We have not yet reviewed Pharma Mar's disclosures for Climate Targets data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Pharma Mar's data?

Start your 30-day free trial to request a data review for Pharma Mar.

Start Free Trial

Legal Center Contact Us